0001628280-22-005124.txt : 20220304
0001628280-22-005124.hdr.sgml : 20220304
20220304161151
ACCESSION NUMBER: 0001628280-22-005124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colao Massimilano
CENTRAL INDEX KEY: 0001837645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 22714186
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: BC V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_164642829060367.xml
FORM 4
X0306
4
2022-03-02
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001837645
Colao Massimilano
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Commercial Officer
Common Stock
2022-03-02
4
A
0
8500
0
A
16700
D
Common Stock
2022-03-02
4
S
0
3205
12.01
D
13495
D
Restricted Stock Unit
2022-03-02
4
A
0
104080
0
A
Common Shares
104080.0
104080
D
Stock Option (right to buy)
12.01
2022-03-02
4
A
0
178063
0
A
2032-03-02
Common Stock
178063.0
178063
D
On March 18, 2021, the Reporting Person was granted stock based performance awards ("Performance Awards") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration.
Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date.
One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
/s/ Massimiliano Colao
2022-03-04